HARVARD BIOSCIENCE INC — Director's Dealing 2020

Jun 19, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2020-06-11

Reporting Person: KENNEDY JOHN F (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-11	Common Stock	D	3534	$0.00	Disposed	336259	Direct
2020-06-18	Common Stock	A	28100	$0.00	Acquired	364359	Direct

Footnotes

F1: On January 2, 2020, the Reporting Person received a retainer award of 24,200 restricted stock units of the Issuer, vesting in four equal installments on March 31, 2020, June 30, 2020, September 30, 2020 and December 31, 2020. 6,400 of the restricted stock units were granted in connection with the Reporting Person's serving as chair of the Issuer's Audit Committee. On June 11, 2020, the Reporting Person stepped down from serving as chair of the Audit Committee, remaining as a member. In accordance with the Issuer's non- employee director compensation policy, the Reporting Person forfeited 3,534 restricted stock units as a result of the committee change.

F2: Includes (a) a restricted stock unit award of 13,350 remaining unvested restricted stock units vesting in equal quarterly installments on June 30, 2020, September 30, 2020 and December 31, 2020, and (b) 322,909 shares of common stock held by the Reporting Person.

F3: Represents an award of 28,100 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after June 11, 2020, immediately prior to the commencement of such meeting, and (ii) June 18, 2021.

F4: Includes (a) the shares and awards described in footnote (2) above, and (b) the award described in footnote (3) above.